Literature DB >> 23080443

Resolving conflicting comparative effectiveness research in critical care*.

Christopher W Seymour, Jeremy M Kahn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23080443      PMCID： PMC3655079          DOI： 10.1097/CCM.0b013e31826536b7

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  14 in total

1.  Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop.

Authors:  G D Rubenfeld; D C Angus; M R Pinsky; J R Curtis; A F Connors; G R Bernard
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

2.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

3.  Intensive insulin therapy in critically ill patients.

Authors:  G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

4.  Contradicted and initially stronger effects in highly cited clinical research.

Authors:  John P A Ioannidis
Journal:  JAMA       Date:  2005-07-13       Impact factor: 56.272

5.  Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods.

Authors:  Thérèse A Stukel; Elliott S Fisher; David E Wennberg; David A Alter; Daniel J Gottlieb; Marian J Vermeulen
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

6.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

7.  Confounding by indication: an example of variation in the use of epidemiologic terminology.

Authors:  M Salas; A Hofman; B H Stricker
Journal:  Am J Epidemiol       Date:  1999-06-01       Impact factor: 4.897

8.  Placing trials in context using Bayesian analysis. GUSTO revisited by Reverend Bayes.

Authors:  J M Brophy; L Joseph
Journal:  JAMA       Date:  1995-03-15       Impact factor: 56.272

9.  Drotrecogin alfa (activated) in adults with septic shock.

Authors:  V Marco Ranieri; B Taylor Thompson; Philip S Barie; Jean-François Dhainaut; Ivor S Douglas; Simon Finfer; Bengt Gårdlund; John C Marshall; Andrew Rhodes; Antonio Artigas; Didier Payen; Jyrki Tenhunen; Hussein R Al-Khalidi; Vivian Thompson; Jonathan Janes; William L Macias; Burkhard Vangerow; Mark D Williams
Journal:  N Engl J Med       Date:  2012-05-22       Impact factor: 91.245

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272
View more
  2 in total

1.  Different research designs and their characteristics in intensive care.

Authors:  Wagner Luis Nedel; Fernando da Silveira
Journal:  Rev Bras Ter Intensiva       Date:  2016-09

2.  Adoption and Deadoption of Medications to Treat Hospitalized Patients With COVID-19.

Authors:  Ian J Barbash; Billie S Davis; John S Minturn; Jeremy M Kahn
Journal:  Crit Care Explor       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.